Literature DB >> 19131166

Examination of the photograph series of daily activities (PHODA) scale in chronic low back pain patients with high and low kinesiophobia.

Zina Trost1, Christopher R France, James S Thomas.   

Abstract

The current study examined the Photograph Series of Daily Activities (PHODA) Scale in a sample of chronic low back pain patients with high and low levels of kinesiophobia (pain-related fear). Thirty-three participants completed a modified version of the PHODA (PHODA-M) that obtained ratings of both anticipated pain and harm. Participants' responses on the PHODA-M were compared to predicted and experienced pain and harm ratings collected during a graded-difficulty reaching task. Individuals with high kinesiophobia reported higher pain and harm expectancies for PHODA-M stimuli, as well as greater predicted and experienced pain and harm in response to movement performance. In comparison to low fear participants, high fear participants showed larger correlations between pain expectancies for movements depicted in the PHODA and their ratings of predicted and experienced pain on each movement comprising the reaching task. Additionally, high fear participants showed larger associations between the perceived harmfulness of PHODA activities and predicted and experienced harm ratings in response to the reaching task. Implications for the findings are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19131166     DOI: 10.1016/j.pain.2008.11.016

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  14 in total

1.  A brief primary care intervention to reduce fear of movement in chronic low back pain patients.

Authors:  Thomas P Guck; Raymond V Burke; Christopher Rainville; Dreylana Hill-Taylor; Dustin P Wallace
Journal:  Transl Behav Med       Date:  2015-03       Impact factor: 3.046

Review 2.  [Exposure therapy for chronic back pain].

Authors:  J A Glombiewski
Journal:  Schmerz       Date:  2018-08       Impact factor: 1.107

3.  Virtual immersive gaming to optimize recovery (VIGOR) in low back pain: A phase II randomized controlled trial.

Authors:  Christopher R France; James S Thomas
Journal:  Contemp Clin Trials       Date:  2018-05-03       Impact factor: 2.226

4.  Learning about pain through observation: the role of pain-related fear.

Authors:  Zina Trost; Christopher R France; Tine Vervoort; Jane M Lange; Liesbet Goubert
Journal:  J Behav Med       Date:  2012-12-21

5.  Fear of pain in children and adolescents with neuropathic pain and complex regional pain syndrome.

Authors:  Laura E Simons
Journal:  Pain       Date:  2016-02       Impact factor: 7.926

6.  Personality Type Influences Attentional Bias in Individuals with Chronic Back Pain.

Authors:  Zoë C Franklin; Paul S Holmes; Nickolas C Smith; Neil E Fowler
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

7.  Predictive Value of the Fear-Avoidance Model on Functional Capacity Evaluation.

Authors:  Johanne Tüscher; Cyrille Burrus; Philippe Vuistiner; Bertrand Léger; Gilles Rivier; François Luthi
Journal:  J Occup Rehabil       Date:  2018-09

8.  Pain-Related Fear-Dissociable Neural Sources of Different Fear Constructs.

Authors:  Michael Lukas Meier; Andrea Vrana; Barry Kim Humphreys; Erich Seifritz; Philipp Stämpfli; Petra Schweinhardt
Journal:  eNeuro       Date:  2019-01-03

9.  Fear and difficulty perceived when visualizing therapeutic exercise in patients with chronic low back pain: A cross-sectional study.

Authors:  Marcos Pérez-Fernández; Sergio Lerma-Lara; Raúl Ferrer-Peña; Alfonso Gil-Martínez; Ibai López-de-Uralde-Villanueva; Alba Paris-Alemany; Héctor Beltrán-Alacreu; Roy La Touche
Journal:  J Exerc Rehabil       Date:  2015-12-31

10.  Sensor-based postural feedback is more effective than conventional feedback to improve lumbopelvic movement control in patients with chronic low back pain: a randomised controlled trial.

Authors:  Thomas Matheve; Simon Brumagne; Christophe Demoulin; Annick Timmermans
Journal:  J Neuroeng Rehabil       Date:  2018-09-26       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.